Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-30 @ 7:31 PM
Study NCT ID:
NCT05191004
Status:
WITHDRAWN
Last Update Posted:
2023-07-11
First Post:
2021-12-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
Sponsor:
Nuvation Bio Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-22
First Submit QC Date:
None
Study First Post Date:
2022-01-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-10
Last Update Post Date:
2023-07-11
Last Update Post Date Type:
ACTUAL